Alantolactone inhibits T-cell lymphoma progression by suppressing CD47 expression via the PI3K/AKT and ERK signaling pathways

Xiaodong Li(Ningbo Medical Center Lihuili Hospital), Ni Li(Ningbo Medical Center Lihuili Hospital)
Research Square
January 9, 2026
10.21203/rs.3.rs-8529840/v1
Cited by 0

Related Papers

No related papers found

Powered by citation graph analysis